Medical ETF (MEDX) Touches New 52-Week High

Key Takeaways MEDX touched a new 52-week high, rising 49.9% from its $23.46 low.The ETF targets patented first-line pharma and biologics, charging 85 bps in fees.A 28.43 weighted alpha signals potential for further near-term gains.For investors seeking momentum, the Horizon Kinetics Medical ETF (MEDX) is probably on the radar now. The fund just hit a 52-week high and is up 49.9% from its 52-week low price of $23.46 per share.  But are there more gains in store for this ETF? Let’s take a quick look at the fu ...